Who to follow: HealthTech executives
DG

Doug Godshall

Chairman and CEO · Galvanize Therapeutics

Professional source · Company profile

MedTech & Devices

Why follow Doug

Doug Godshall is Chairman and CEO of Galvanize Therapeutics, which closed a $130 million Series D in November 2026.

Writes about

Galvanize Therapeutics

Best for